Therapeutic approaches to diabetic nephropathy—beyond the RAS

@article{FernndezFernndez2014TherapeuticAT,
  title={Therapeutic approaches to diabetic nephropathy—beyond the RAS},
  author={Beatriz Fern{\'a}ndez-Fern{\'a}ndez and Alberto Ortiz and Carmen G{\'o}mez-Guerrero and Jes{\'u}s Egido},
  journal={Nature Reviews Nephrology},
  year={2014},
  volume={10},
  pages={325-346}
}
Despite improvements in glycaemic and blood pressure control, and the efficacy of renin–angiotensin system (RAS) blockade for proteinuria reduction, diabetic nephropathy is the most frequent cause of end-stage renal disease in developed countries. This finding is consistent with the hypothesis that key pathogenetic mechanisms leading to progression of renal disease are not modified or inactivated by current therapeutic approaches. Although extensive research has elucidated molecular signalling… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 4 times over the past 90 days. VIEW TWEETS

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 198 references

A1.72 Baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis: safety and efficacy in an open-label, long-term extension study

  • P Taylor
  • Ann. Rheum. Dis
  • 2014

Similar Papers

Loading similar papers…